| Characterization of ACE and ACE2 expression within different organs of the NOD mouse H Roca-Ho, M Riera, V Palau, J Pascual, MJ Soler International journal of molecular sciences 18 (3), 563, 2017 | 343 | 2017 |
| Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ... Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019 | 103 | 2019 |
| Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria M Riera, L Anguiano, S Clotet, H Roca-Ho, M Rebull, J Pascual, MJ Soler American Journal of Physiology-Renal Physiology 310 (6), F534-F546, 2016 | 69 | 2016 |
| The human CD38 monoclonal antibody daratumumab shows antitumor activity and hampers leukemia–microenvironment interactions in chronic lymphocytic leukemia A Matas-Céspedes, A Vidal-Crespo, V Rodriguez, N Villamor, J Delgado, ... Clinical Cancer Research 23 (6), 1493-1505, 2017 | 62 | 2017 |
| Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse M Riera, E Márquez, S Clotet, J Gimeno, H Roca-Ho, J Lloreta, ... PloS one 9 (1), e84683, 2014 | 61 | 2014 |
| 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ... Journal for immunotherapy of cancer 8 (1), 2020 | 43 | 2020 |
| NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL C Prieto, B López-Millán, H Roca-Ho, RW Stam, D Romero-Moya, ... Leukemia 32 (3), 633-644, 2018 | 39 | 2018 |
| NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia B Lopez-Millan, D Sanchéz-Martínez, H Roca-Ho, F Gutiérrez-Agüera, ... Leukemia 33 (7), 1557-1569, 2019 | 38 | 2019 |
| Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus J Castaño, C Bueno, S Jiménez-Delgado, H Roca-Ho, MF Fraga, ... Stem cell research 21, 137-140, 2017 | 36 | 2017 |
| Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice H Roca-Ho, V Palau, J Gimeno, J Pascual, MJ Soler, M Riera Laboratory Investigation 100 (9), 1169-1183, 2020 | 33 | 2020 |
| A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ... Molecular Therapy 30 (2), 550-563, 2022 | 29 | 2022 |
| Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease B Lopez-Millan, R Diaz de la Guardia, H Roca-Ho, CM García-Herrero, ... Experimental & molecular medicine 49 (2), e290-e290, 2017 | 24 | 2017 |
| Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL O Molina, M Vinyoles, I Granada, H Roca-Ho, F Gutierrez-Agüera, ... Blood, The Journal of the American Society of Hematology 136 (3), 313-327, 2020 | 22 | 2020 |
| Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions C Bueno, FJ Calero-Nieto, X Wang, R Valdés-Mas, F Gutiérrez-Agüera, ... haematologica 104 (6), 1189, 2019 | 22 | 2019 |
| IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non … B Lopez-Millan, R Diaz de la Guardia, H Roca-Ho, E Anguita, AB Islam, ... Oncoimmunology 7 (9), e1477460, 2018 | 14 | 2018 |
| Robustness of catalytically dead Cas9 activators in human pluripotent and mesenchymal stem cells P Petazzi, R Torres-Ruiz, A Fidanza, H Roca-Ho, F Gutierrez-Agüera, ... Molecular Therapy-Nucleic Acids 20, 196-204, 2020 | 13 | 2020 |
| ACE2 and ACE in acute and chronic rejection after human heart transplantation MJ Soler, M Batlle, M Riera, B Campos, JT Ortiz-Perez, L Anguiano, ... International Journal of Cardiology 275, 59-64, 2019 | 13 | 2019 |
| Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic … RD de la Guardia, B Lopez-Millan, H Roca-Ho, C Bueno, ... haematologica 104 (2), e54, 2019 | 12 | 2019 |
| Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ... Journal for immunotherapy of cancer 8 (2), 2020 | 11 | 2020 |
| Engraftment characterization of risk-stratified AML in NSGS mice R Díaz de la Guardia, T Velasco-Hernandez, F Gutiérrez-Agüera, ... Blood advances 5 (23), 4842-4854, 2021 | 10 | 2021 |
Talia Velasco-HernandezAssistant professor Serra Hunter. Universidad de Barcelona在 ub.edu 的电子邮件经过验证
Talia Velasco-HernandezAssistant professor Serra Hunter. Universidad de Barcelona在 ub.edu 的电子邮件经过验证